Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Acquisition And Total Voting Rights

25 Feb 2026 07:00

RNS Number : 2523U
Norman Broadbent PLC
25 February 2026
 

 

 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018

 

Norman Broadbent plc

("Norman Broadbent", the "Group" or the "Company")

 

Acquisition

And

Total Voting Rights

 

Society Limited

 

Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, is pleased to announce the acquisition of Society Limited ("Society"), a specialist UK based executive search firm on a cash and debt free basis (the "Acquisition").

 

Established in 2010 and headquartered in London, Society is a provider of executive search and related services and is a certified B Corporation. It has developed specialisms in placing Board level positions in the third sector, including not-for-profit, charities, education and public sector organisations, and in the Travel & Hospitality sector. The business is being acquired with five full-time staff who will remain with the business post the transaction. 

 

Acquisition headlines

 

The acquisition is in line with Norman Broadbent's strategy to complement its organic growth with disciplined acquisitions where it makes strategic and financial sense to do so.

 

Society is a highly complementary business addition to the Norman Broadbent platform, strengthening and deepening the Group's existing capability. The acquisition:

 

· accelerates the Group's expansion into the third sector where Society has an established presence and track record. The third sector has been identified in Norman Broadbent's M&A mapping as a target sector which offers attractive growth potential for executive and board search, interim management and other leadership consulting and advisory services both in the UK and internationally

· strengthens the Group's capability in the Travel & Hospitality sector, deepening and broadening the Group's existing Consumer Markets practice. It also aligns with the Group's aerospace and aviation specialism which has demonstrated particularly strong fee momentum over the last 12 months

· brings an established and well-regarded brand identity based on long-standing relationships and a strong sense of purpose as illustrated by its B-Corp status. Reflecting this, whilst the team will be fully integrated, the Society business will continue to trade under the Society brand post completion of the acquisition

· provides the opportunity to expand Norman Broadbent's established Board Practice, serving plc and private companies, to third sector clients 

· diversifies the Group's revenue mix

· grows headcount through the cost-effective recruitment of a team of five, including two established fee earners plus two experienced Principals on a journey to becoming fully fledged fee-earners.

 

Financial impact

 

· 100% of the issued share capital of Society Limited is being acquired for a consideration of £33,001 which will be funded through the issue of 14,194 new shares. The Acquisition is being completed on a debt and cash free basis

· the acquisition provides valuable underpinning to current year earnings expectations and provides an additional platform for future organic growth. A number of restructuring measures were realised by Society prior to the Acquisition, and this provides realised cost savings for the Group going forward

· Society generated net fee income of £0.7m in each of the last two financial years to 31 December 2025, and was broadly break-even in the year to 31 December 2025 at the operating level (FY24: (£0.1m)). As at 31 January 2026, gross assets of Society were £0.1m(1).

 

Kevin Davidson, CEO of Norman Broadbent, commented: "We are delighted to welcome Simon and his team to Norman Broadbent. We are excited about the growth opportunity Society offers and believe the Society business and its people will do incredibly well on our platform. We have recruited high calibre individuals with a track record of fee generation in sectors that are naturally aligned with our long-term growth plans. We have a lot of respect for their purpose driven approach to business with their Equity, Diversity and Inclusion focus and ethical business principles at the core of how they work. We see a very strong cultural fit with our approach and a shared vision of the opportunity to scale and grow whilst doing business the right way. This is the first acquisition we have undertaken in the modern era of Norman Broadbent plc and we remain committed to delivering value for shareholders through our ambitious growth strategy. We will continue to look at opportunities to bring high quality people to the business both through organic investment and disciplined M&A."

 

Simon Lucas, CEO and Founder of Society, commented: "We are excited to be joining the Norman Broadbent group and see a great deal of synergy with its purpose driven culture, strong brand identity and the impressive platform they have built. We are delighted to have this opportunity at this stage of our journey to benefit from the right support and contribute our growth as part of Norman Broadbent."

 

Further Information and total voting rights

 

Under the terms of the Acquisition, 14,194 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") are being issued to the vendor, conditional on admission ("Admission"). Application will be made for 14,194 new Ordinary Shares to be admitted to trading on AIM. Admission is expected to become effective on 3 March 2026.

 

The new Ordinary Shares issued are subject to a lock-up agreement for a period of 12 months from completion (subject to customary carve-outs, including with the consent of the Company's nominated adviser from time to time) and a further 6 months' orderly marketing restriction thereafter.

 

Following Admission, Norman Broadbent plc will have 1,925,688 Ordinary Shares in issue. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. The total number of voting rights in the Company immediately following Admission will therefore be 1,925,688.

 

Footnotes

[1] Unaudited management accounts

 

Contacts: 

 

Norman Broadbent plc 

Via Gracechurch Group

Kevin Davidson, CEO 

Mehr Malik, CFO

Cavendish Capital Markets Limited (Nominated Adviser and Broker)  

+44 (0)20 7220 0500

Julian Blunt, Seamus Fricker, Andrea Callaghan - Corporate Finance

Jasper Berry, Matt Lewis - Sales / Corporate Broking 

 

Gracechurch Group (Financial Media & Investor Relations)

+44 (0)20 4582 3500

Murdo Montgomery

normanbroadbent@gracechurchpr.com

Tommy Bryson

Anysia Virdi

  

 

About Norman Broadbent:

 

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.

 

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

 

www.normanbroadbent.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQLZLLLQLLBBBL
Date   Source Headline
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase
23rd Aug 20227:00 amRNSDirectorate Change
16th Aug 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSChange of Adviser
20th Jul 20224:08 pmRNSDirector/PDMR Dealing
11th Jul 20227:00 amRNSTrading Update
29th Jun 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:14 pmRNSResult of AGM
7th Jun 20228:59 amRNSHolding(s) in Company
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM
20th May 20225:49 pmRNSIssue of Convertible Loan Notes
11th May 20224:16 pmRNSDirector resignation
18th Mar 20227:00 amRNSGrant of Options to Directors and Employees
2nd Mar 20227:00 amRNSFY2021 Trading Update
7th Feb 20227:00 amRNSBoard Changes
7th Dec 20213:50 pmRNSHolding(s) in Company
6th Dec 202110:18 amRNSSubscription
2nd Dec 20217:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.